TCR V Beta13.1 Antikörper
Kurzübersicht für TCR V Beta13.1 Antikörper (ABIN7670127)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Purified Anti-Human TCRVβ13.1 Antibody[H131]
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- ≥ 1 mg/mL
-
Buffer
- Phosphate buffered solution, pH 7.2, containing 0.05 % proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- avoid freeze / thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- TCR V Beta13.1
-
Andere Bezeichnung
- TCRVbeta13.1
-
Hintergrund
- TRAV13-,TRAV13-1,TCR Vβ13.1 is a variant of the TCR β chain. The receptor is complexed with the TCR α chain and belongs to the immunoglobulin superfamily. It is expressed on a subset of T cells and some T cell clones. Variability in the β chain is generated by Vβ, Dβ, and Jβ gene rearrangement, while variability in the α chain is generated by Vα and Jα rearrangement. TCR Vβ13.1 has been shown to be related to antigen recognition and inflammation as well as diseases, such as HIV and multiple sclerosis.
-
UniProt
- A0A0B4J241
Target
-